Enterprise Value
$1.45 B
-$34.64 M-2.33%
Wed, 11 Dec 2024 21:08:20 GMT
Summary:
Spyre Therapeutics enterprise value is currently $1.45 billion, with a fall of -$34.64 million (-2.33%) during the most recent trading day. Over the past year, it has increased by +$889.32 million (+158.92%). SYRE enterprise value is now -29.05% below its all-time high of $2.04 billion.SYRE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -2.3% | -2.2% | -2.2% |
| 1 m1 month | -29.1% | -28.1% | -37.0% |
| 3 m3 months | +1.3% | +3.0% | -10.6% |
| 6 m6 months | -14.8% | -21.2% | -31.8% |
| ytdytd | +146.8% | +96.0% | +20.4% |
| 1 y1 year | +158.9% | +133.9% | +43.5% |
| 5 y5 years | +574.6% | +564.0% | -86.9% |
SYRE Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $2.04 B | -29.1% | $1.31 B | +10.2% |
| 3 m | 3 months | $2.04 B | -29.1% | $1.31 B | +10.2% |
| 6 m | 6 months | $2.04 B | -29.1% | $474 M | +205.4% |
| 1 y | 1 year | $2.04 B | -29.1% | $444 M | +226.4% |
| 3 y | 3 years | $2.04 B | -29.1% | -$224 M | +746.6% |
| 5 y | 5 years | $2.04 B | -29.1% | -$224 M | +746.6% |
| alltime | all time | $2.04 B | -29.1% | -$224 M | +746.6% |
Spyre Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $1.45 B(+146.8%) |
| 2023 | $587.06 M(<-9900.0%) |
| 2022 | -$826.50 K(-100.4%) |
| 2021 | $224.35 M(-23.4%) |
| Date | Value |
|---|---|
| 2020 | $292.80 M(+40.8%) |
| 2019 | $208.02 M(+31.4%) |
| 2018 | $158.35 M(+104.7%) |
| 2017 | $77.37 M(+624.9%) |
| 2016 | $10.67 M |
FAQ
- What is Spyre Therapeutics enterprise value?
- What is the all time high enterprise value for Spyre Therapeutics?
- What is SYRE enterprise value year-to-date change?
- What is Spyre Therapeutics enterprise value year-on-year change?
What is Spyre Therapeutics enterprise value?
The current enterprise value of SYRE is $1.45 B
What is the all time high enterprise value for Spyre Therapeutics?
Spyre Therapeutics all-time high enterprise value is $2.04 B
What is SYRE enterprise value year-to-date change?
Spyre Therapeutics enterprise value has changed by +$861.85 M (+146.81%) since the beginning of the year
What is Spyre Therapeutics enterprise value year-on-year change?
Over the past year, SYRE enterprise value has changed by +$889.32 M (+158.92%)